Tag: Conformal Medical

Conformal Medical Announces Launch of CONFORM Pivotal Trial

Study to support U.S. FDA approval of the novel CLAAS® implant forleft atrial appendage occlusion (LAAO) and stroke prevention NASHUA, N.H., June 17, 2022 /PRNewswire/ — Conformal Medical, Inc., a medical device company developing next-generation LAAO technology, today announced the launch of the CONFORM pivotal trial with the enrollment of the first patients at two U.S. sites. The […]

Conformal Medical’s CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

U.S. and European feasibility studies demonstrate early success of novel conformable foam matrix implant for LAAC NASHUA, N.H., Oct. 15, 2020 /PRNewswire/ — Conformal Medical, Inc., a privately held medical device company developing next generation left atrial appendage closure (LAAC) technology, today announced positive clinical data from First-in-Human studies performed in the U.S. and Prague.  […]

Conformal Medical Secures $85M in Series C Financing

Funding to Support U.S. Pivotal Trial of CLAAS® Stroke Prevention Technology NASHUA, N.H., Aug. 6, 2020 /PRNewswire/ — Conformal Medical, Inc., a medical device company focused on reducing stroke in patients with atrial fibrillation (AFib), today announced it has secured $85 million in Series C financing. The financing syndicate included participation from new investors Fidelity Management […]

Conformal Medical Announces $9 million Series B Financing

NASHUA, N.H., Dec. 3, 2018 /PRNewswire/ — Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Seal for LAA occlusion, has secured $9 million in Series B funding. Conformal is developing proprietary seal technology for the prevention of stroke in patients with atrial fibrillation (AFib). Over five million people in the United States have AFib, […]